The use of intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (tPA) given within 3 hours of onset or within 3–4.5 hours of specific selected strokes in improving the outcome of patients with acute ischemic stroke (AIS) has been well demonstrated [1, 2]. This evidence concerns the gene PLAT and stroke disorder.